Furthermore, analyses of the levels of ROS and MDA and mitochondrial membrane potential further confirmed the level of ferroptosis was decreased in sorafenib-sensitive HCC cells with overexpression of FNDC5 compared with sorafenib-sensitive HCC cells (Figures 6C, , D). This evidence concerns the gene FNDC5 and hepatocellular carcinoma.